The Anderson Perspective

Machina Medical's novel hydrogel barrier, MFUSE, gains FDA clearance, promising to control severe bleeding in seconds and disrupt the hemostasis market.

A federal ban on selling nicotine pouches in convenience stores was meant to protect youth, but critics say it's fueling a dangerous, illegal market.

As Bell Let's Talk Day returns, a look at its 16-year, $194M journey reveals a complex legacy of groundbreaking awareness, crucial funding, and intense controversy.

Illinois startup NVISAGE challenges industry giants with its subscription-free, pro-grade NEO-E portable launch monitor, making its debut in Europe.

Profusa launches its Lumee system for research, aiming to capture a piece of the $47B CRO market and revolutionize drug development with real-time data.

A Perth agency used AI to transform a local gift shop into a million-dollar brand, signaling a major shift in digital marketing. Here's how they did it.

By popular demand, the premier business awards for the Asia-Pacific region offers a final chance for recognition. Here's why winning matters.

As Fortis prepares its 2025 financial report, investors eye its massive capital plan and strategy for navigating the energy transition and surging demand.

AGCO affirmed its $0.29 quarterly dividend, signaling financial stability while navigating mixed global demand and investing in the future of farming tech.

Gov. Mills allows a tribal-led online casino bill to pass, sparking a fierce debate between economic hopes for tribes and fears of a public health crisis.

VTS reports record 2025 growth, crediting its new AI platform for transforming operations. But what does this mean for the future of property tech?

Azamara Cruises unveils its largest-ever investment: new penthouse suites, reimagined dining, and ship-wide upgrades to redefine small-ship luxury.

Basketball legends and the Prostate Cancer Foundation unite in a new initiative to fight late detection, urging men of color to prioritize life-saving screenings.

InterAx's AI platform and Alveus's R&D expertise combine in a new partnership to develop a next-gen obesity drug with durable results and better tolerability.

A new documentary reveals the perilous lives of power grid workers and their robotic partners safeguarding China's massive energy artery in the mountains.

Following a merger and major capital injection, NDH REIT diversifies into veterinary real estate and executes a $92M acquisition spree. Here's how.

AI automation leader Esker brings on a seasoned CFO with a history of IPOs and tech transformations, signaling a new phase of aggressive global expansion.

Adial Pharmaceuticals files a key patent to protect its personalized Alcohol Use Disorder drug, AD04, until 2045, signaling a new era for addiction medicine.

The deal merges IMS's global litigation support with First Court's jury research tech, signaling a major shift toward data-driven trial strategy.

A new global league is bringing elite basketball to Tokyo, but its revolutionary athlete-owner model, starring Japan's Mai Yamamoto, is the real game-changer.